A University of Arizona researcher has received a $450,000 grant to expand her clinical study of Alzheimer’s disease.
Roberta Diaz Brinton, PhD, is focused on developing the first regenerative therapeutic for the disease.
Dr. Brinton is studying neurogenesis, which is the process of growing new signaling cells or neurons.
Alzheimer’s patients lose a number of these neurons in certain parts of the brain.
But, Dr. Brinton has discovered that allopregnanolone, a steroid found in the brain, can stimulate brain cells and repair damaged tissue.
In previous studies, Dr. Brinton has found that this process restores cognitive function and can reduce Alzheimer’s pathology in some patients.
The grant will be used to conduct larger clinical studies and manufacture allopregnanolone.
Dr. Brinton is the director of the Center for Innovation in Brain Science at the University of Arizona Health Sciences.
The grant is coming from the Alzheimer’s Drug Discovery Foundation.